top of page
Browse by category
Search
Pfizer to acquire Metsera and its next-generation obesity portfolio
Pfizer and Metsera have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical...
Severe obesity associated with reduced prevalence of cancer screenings
In a recent cross-sectional study, researchers from Pennington Biomedical Research Center found that severe obesity is associated with a...
The future of obesity management – quintuple and other super polyagonists
In a session at this year’s Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria, researchers...
First commercial patient treated with Morphic Medical’s RESET device
Morphic Medical has announced that the first commercial patient has been treated with RESET, the company’s therapy designed to target the...
ASC47 in combination with semaglutide has 56.2% reduction in body weight semaglutide monotherapy
Ascletis Pharma’s ASC47, a muscle-preserving weight loss drug candidate, in combination with semaglutide demonstrated up to 56.2% greater...
Metamaterial could transform future of implantable and ingestible medical devices
Researchers led by Rice University's Yong Lin Kong have developed a soft but strong metamaterial that can be controlled remotely to...
Browse by tag
bottom of page